Quadrant Capital Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Quadrant Capital Group’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-55	Closed	-$5K	–	2779
2021 Q4	$5K	Buy	55 +31	+129%	+$2.04K	﹤0.01%	1923
2021 Q3	$1K	Sell	24 -9	-27%	-$532	﹤0.01%	2461
2021 Q2	$2K	Buy	33 +19	+136%	+$1.24K	﹤0.01%	2190
2021 Q1	$1K	Buy	14 +3	+27%	+$231	﹤0.01%	2354
2020 Q4	$1K	Hold	11	–	–	﹤0.01%	2252
2020 Q3	$1K	Buy	11 +6	+120%	+$400	﹤0.01%	2121
2020 Q2	$0	Hold	5	–	–	﹤0.01%	2481
2020 Q1	$0	Buy	+5	New	+$229	﹤0.01%	2334
2019 Q3	–	Sell	-439	Closed	-$25K	–	2430
2019 Q2	$25K	Buy	+439	New	+$22.7K	﹤0.01%	1556

Quadrant Capital Group's ARNA Position: Q1 2022 in Review

Quadrant Capital Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 55 shares — an estimated $5K sold.

Quadrant Capital Group first reported a position in ARNA in Q2 2019 and held it in 9 quarters. The position peaked at $25K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Quadrant Capital Group reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Quadrant Capital Group sold 55 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $5K.
Quadrant Capital Group first reported a position in Arena Pharmaceuticals Inc in Q2 2019 and held it in 9 quarters.
Quadrant Capital Group's Arena Pharmaceuticals Inc position peaked at $25K in Q2 2019.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Quadrant Capital Group's 13F filing for Q1 2022, filed 6 May 2022.